lar MRD monitoring of ALL patients in Turkey (original) (raw)
Minimal Residual Disease (MRD) Detection with Translocations and T-Cell Receptor and Immunoglobulin Gene Rearrangements in Adult Acute Lymphoblastic Leukaemia Patients: A Pilot Study
Ümit Üre
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2008
View PDFchevron_right
Minimal residual disease ( MRD ) detection with translocations and T-cell receptor and immunoglobulin gene rearrangements in adult acute lymphoblastic leukemia patients : a pilot study
Ugur Ozbek
2008
View PDFchevron_right
Minimal Residual Disease (MRD) in Leukemia
Irina Trandafir
2016
View PDFchevron_right
Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients
Yasutaka Kakinoki, Takeshi Kondo
American Journal of Hematology, 2005
View PDFchevron_right
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia
Giovanni Cazzaniga
British Journal of Haematology, 2011
View PDFchevron_right
Flow Cytometry Based MRD and Its Impact on Survival Outcome in Children and Young Adults with ALL: A Prospective Study from a Tertiary Cancer Centre in Southern India
Rajesh Bhola
Indian Journal of Hematology and Blood Transfusion, 2019
View PDFchevron_right
Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia
sevgi yetgin
British Journal of Haematology, 2002
View PDFchevron_right
Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions
Alberto Orfao
British Journal of Haematology, 2013
View PDFchevron_right
Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL
Vassilis Vasdekis
Leukemia & lymphoma, 2018
View PDFchevron_right
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Grazia Fazio
Leukemia
View PDFchevron_right
Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
Owen Smith, Prerna Tewari
British Journal of Haematology, 2009
View PDFchevron_right
Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience
A. Cizmar
Neoplasma, 2010
View PDFchevron_right
Detection of minimal residual disease in pediatric patients with acute lymphoblastic leukemia and its prognostic significance
Gunnur Deniz
World J Pediatr, 2007
View PDFchevron_right
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
Arcangelo Liso
Leukemia, 2000
View PDFchevron_right
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group
T. Klingebiel
Bone Marrow Transplantation, 2003
View PDFchevron_right
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia
Francesco Fabbiano
British Journal of Haematology, 2003
View PDFchevron_right
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
Chantal Brouzes
Leukemia, 2012
View PDFchevron_right
Sensitive and Specific Measurement of Minimal Residual Disease in Acute Lymphoblastic Leukemia
Rosemary Sutton
The Journal of Molecular Diagnostics, 2009
View PDFchevron_right
Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR)
Sigal Manor
Pediatric Blood & Cancer, 2009
View PDFchevron_right
Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
Lars P Ryder, Finn Wesenberg
Journal of Immunological Methods, 2000
View PDFchevron_right
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
Alessandra Santoro
Leukemia & Lymphoma, 2019
View PDFchevron_right
Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
Alexander Meleshko, Olga Aleinikova, Olga Krasko
Leukemia Research, 2011
View PDFchevron_right
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
Helene Cave
Leukemia, 2009
View PDFchevron_right
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Adriana Plesa
Blood
View PDFchevron_right
The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood
Sim-Hee Neoh
Leukemia, 1997
View PDFchevron_right
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia
Anuruddhika Dissanayake, Rosemary Sutton
View PDFchevron_right
Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia
Michael Brisco, Alexander Morley
British Journal of Haematology, 1997
View PDFchevron_right
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell recepto...
Helene Cave
Haematologica, 2017
View PDFchevron_right
Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia
F. Behm
Leukemia, 1999
View PDFchevron_right
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia
Simone A Joosten
Leukemia, 2001
View PDFchevron_right
Clinical Relevance of Minimal Residual Disease Detection in Adult Acute Myeloid Leukemia
Francesco Buccisano
Journal of Hematotherapy & Stem Cell Research, 2002
View PDFchevron_right